<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD with MathML3 v1.1 20151215//EN" "JATS-journalpublishing1-mathml3.dtd">
<article dtd-version="1.1"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:mml="http://www.w3.org/1998/Math/MathML">
    <front>
        <journal-meta>
            <journal-id></journal-id>
            <issn></issn>
        </journal-meta>
        <article-meta>
            <title-group>
                <article-title></article-title>
            </title-group>
            <pub-date>
                <year></year>
            </pub-date>
        </article-meta>
    </front>
    <back>
        <ref-list>
            <ref id="b1">
                <label>1. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Erkkinen</surname>
                            <given-names>MG</given-names>
                        </name>, 
                        <name>
                            <surname>Kim</surname>
                            <given-names>MO</given-names>
                        </name>, 
                        <name>
                            <surname>Geschwind</surname>
                            <given-names>MD</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases</article-title>. 
                    <source>Cold Spring Harb Perspect Biol</source>. 
                    <year>2018</year>
                    <month>Apr</month>;
                    <volume>10</volume>(
                    <issue>4</issue>):
                    <fpage>a033118</fpage>. 
                    <pub-id pub-id-type="doi">10.1101/cshperspect.a033118</pub-id>
                    <pub-id pub-id-type="pmid">28716886</pub-id>
                    <issn>1943-0264</issn>
                </mixed-citation>
            </ref>
            <ref id="b2">
                <label>2. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Kovacs</surname>
                            <given-names>GG</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine</article-title>. 
                    <source>Int J Mol Sci</source>. 
                    <year>2016</year>
                    <month>Feb</month>;
                    <volume>17</volume>(
                    <issue>2</issue>):
                    <fpage>189</fpage>. 
                    <pub-id pub-id-type="doi">10.3390/ijms17020189</pub-id>
                    <pub-id pub-id-type="pmid">26848654</pub-id>
                    <issn>1661-6596</issn>
                </mixed-citation>
            </ref>
            <ref id="b3">
                <label>3. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Jack</surname>
                            <given-names>CR</given-names>
                            <suffix>Jr</suffix>
                        </name>, 
                        <name>
                            <surname>Bennett</surname>
                            <given-names>DA</given-names>
                        </name>, 
                        <name>
                            <surname>Blennow</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Carrillo</surname>
                            <given-names>MC</given-names>
                        </name>, 
                        <name>
                            <surname>Dunn</surname>
                            <given-names>B</given-names>
                        </name>, 
                        <name>
                            <surname>Haeberlein</surname>
                            <given-names>SB</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>Contributors</collab>
                    </person-group>. 
                    <article-title>NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease</article-title>. 
                    <source>Alzheimers Dement</source>. 
                    <year>2018</year>
                    <month>Apr</month>;
                    <volume>14</volume>(
                    <issue>4</issue>):
                    <fpage>535</fpage>–
                    <lpage>62</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jalz.2018.02.018</pub-id>
                    <pub-id pub-id-type="pmid">29653606</pub-id>
                    <issn>1552-5260</issn>
                </mixed-citation>
            </ref>
            <ref id="b4">
                <label>4. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Vanderschaeghe</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Schaeverbeke</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Bruffaerts</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Vandenberghe</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Dierickx</surname>
                            <given-names>K</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Amnestic MCI patients’ experiences after disclosure of their amyloid PET result in a research context</article-title>. 
                    <source>Alzheimers Res Ther</source>. 
                    <year>2017</year>
                    <month>Dec</month>;
                    <volume>9</volume>(
                    <issue>1</issue>):
                    <fpage>92</fpage>. 
                    <pub-id pub-id-type="doi">10.1186/s13195-017-0321-3</pub-id>
                    <pub-id pub-id-type="pmid">29197423</pub-id>
                    <issn>1758-9193</issn>
                </mixed-citation>
            </ref>
            <ref id="b5">
                <label>5. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>LeWitt</surname>
                            <given-names>PA</given-names>
                        </name>, 
                        <name>
                            <surname>Rezai</surname>
                            <given-names>AR</given-names>
                        </name>, 
                        <name>
                            <surname>Leehey</surname>
                            <given-names>MA</given-names>
                        </name>, 
                        <name>
                            <surname>Ojemann</surname>
                            <given-names>SG</given-names>
                        </name>, 
                        <name>
                            <surname>Flaherty</surname>
                            <given-names>AW</given-names>
                        </name>, 
                        <name>
                            <surname>Eskandar</surname>
                            <given-names>EN</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>AAV2-GAD gene therapy for advanced Parkinson’s disease: a double-blind, sham-surgery controlled, randomised trial</article-title>. 
                    <source>Lancet Neurol</source>. 
                    <year>2011</year>
                    <month>Apr</month>;
                    <volume>10</volume>(
                    <issue>4</issue>):
                    <fpage>309</fpage>–
                    <lpage>19</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S1474-4422(11)70039-4</pub-id>
                    <pub-id pub-id-type="pmid">21419704</pub-id>
                    <issn>1474-4422</issn>
                </mixed-citation>
            </ref>
            <ref id="b6">
                <label>6. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Villemagne</surname>
                            <given-names>VL</given-names>
                        </name>, 
                        <name>
                            <surname>Doré</surname>
                            <given-names>V</given-names>
                        </name>, 
                        <name>
                            <surname>Bourgeat</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Burnham</surname>
                            <given-names>SC</given-names>
                        </name>, 
                        <name>
                            <surname>Laws</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Salvado</surname>
                            <given-names>O</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Aβ-amyloid and Tau Imaging in Dementia</article-title>. 
                    <source>Semin Nucl Med</source>. 
                    <year>2017</year>
                    <month>Jan</month>;
                    <volume>47</volume>(
                    <issue>1</issue>):
                    <fpage>75</fpage>–
                    <lpage>88</lpage>. 
                    <pub-id pub-id-type="doi">10.1053/j.semnuclmed.2016.09.006</pub-id>
                    <pub-id pub-id-type="pmid">27987560</pub-id>
                    <issn>0001-2998</issn>
                </mixed-citation>
            </ref>
            <ref id="b7">
                <label>7. </label>
                <mixed-citation publication-type="book-chapter">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Lin</surname>
                            <given-names>EC</given-names>
                        </name>, 
                        <name>
                            <surname>Alavi</surname>
                            <given-names>A</given-names>
                        </name>
                    </person-group>. 
                    <chapter-title>PET and PET/CT- a clinical guide</chapter-title>. In: 
                    <person-group person-group-type="editor">
                        <name>
                            <surname>Lin</surname>
                            <given-names>EC</given-names>
                        </name>, 
                        <name>
                            <surname>Alavi</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <role>eds</role>
                    </person-group>. 
                    <source>Thieme Medical</source>. 
                    <publisher-loc>New york</publisher-loc>: 
                    <publisher-name>Thieme</publisher-name>; 
                    <year>2009</year>. pp. 
                    <fpage>3</fpage>–
                    <lpage>11</lpage>. 
                    <pub-id pub-id-type="doi">10.1055/b-002-74271</pub-id>
                </mixed-citation>
            </ref>
            <ref id="b8">
                <label>8. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Berti</surname>
                            <given-names>V</given-names>
                        </name>, 
                        <name>
                            <surname>Pupi</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Mosconi</surname>
                            <given-names>L</given-names>
                        </name>
                    </person-group>. 
                    <article-title>PET/CT in diagnosis of dementia</article-title>. 
                    <source>Ann N Y Acad Sci</source>. 
                    <year>2011</year>
                    <month>Jun</month>;
                    <volume>1228</volume>(
                    <issue>1</issue>):
                    <fpage>81</fpage>–
                    <lpage>92</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1749-6632.2011.06015.x</pub-id>
                    <pub-id pub-id-type="pmid">21718326</pub-id>
                    <issn>0077-8923</issn>
                </mixed-citation>
            </ref>
            <ref id="b9">
                <label>9. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Berti</surname>
                            <given-names>V</given-names>
                        </name>, 
                        <name>
                            <surname>Pupi</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Mosconi</surname>
                            <given-names>L</given-names>
                        </name>
                    </person-group>. 
                    <article-title>PET/CT in diagnosis of movement disorders</article-title>. 
                    <source>Ann N Y Acad Sci</source>. 
                    <year>2011</year>
                    <month>Jun</month>;
                    <volume>1228</volume>(
                    <issue>1</issue>):
                    <fpage>93</fpage>–
                    <lpage>108</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1749-6632.2011.06025.x</pub-id>
                    <pub-id pub-id-type="pmid">21718327</pub-id>
                    <issn>0077-8923</issn>
                </mixed-citation>
            </ref>
            <ref id="b10">
                <label>10. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Brown</surname>
                            <given-names>RK</given-names>
                        </name>, 
                        <name>
                            <surname>Bohnen</surname>
                            <given-names>NI</given-names>
                        </name>, 
                        <name>
                            <surname>Wong</surname>
                            <given-names>KK</given-names>
                        </name>, 
                        <name>
                            <surname>Minoshima</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Frey</surname>
                            <given-names>KA</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Brain PET in suspected dementia: patterns of altered FDG metabolism</article-title>. 
                    <source>Radiographics</source>. 
                    <year>2014</year>
                    <month>May-Jun</month>;
                    <volume>34</volume>(
                    <issue>3</issue>):
                    <fpage>684</fpage>–
                    <lpage>701</lpage>. 
                    <pub-id pub-id-type="doi">10.1148/rg.343135065</pub-id>
                    <pub-id pub-id-type="pmid">24819789</pub-id>
                    <issn>0271-5333</issn>
                </mixed-citation>
            </ref>
            <ref id="b11">
                <label>11. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Herholz</surname>
                            <given-names>K</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Guidance for reading FDG PET scans in dementia patients</article-title>. 
                    <source>Q J Nucl Med Mol Imaging</source>. 
                    <year>2014</year>
                    <month>Dec</month>;
                    <volume>58</volume>(
                    <issue>4</issue>):
                    <fpage>332</fpage>–
                    <lpage>43</lpage>.
                    <pub-id pub-id-type="pmid">25391316</pub-id>
                    <issn>1824-4785</issn>
                </mixed-citation>
            </ref>
            <ref id="b12">
                <label>12. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Jack</surname>
                            <given-names>CR</given-names>
                            <suffix>Jr</suffix>
                        </name>, 
                        <name>
                            <surname>Knopman</surname>
                            <given-names>DS</given-names>
                        </name>, 
                        <name>
                            <surname>Jagust</surname>
                            <given-names>WJ</given-names>
                        </name>, 
                        <name>
                            <surname>Petersen</surname>
                            <given-names>RC</given-names>
                        </name>, 
                        <name>
                            <surname>Weiner</surname>
                            <given-names>MW</given-names>
                        </name>, 
                        <name>
                            <surname>Aisen</surname>
                            <given-names>PS</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers</article-title>. 
                    <source>Lancet Neurol</source>. 
                    <year>2013</year>
                    <month>Feb</month>;
                    <volume>12</volume>(
                    <issue>2</issue>):
                    <fpage>207</fpage>–
                    <lpage>16</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S1474-4422(12)70291-0</pub-id>
                    <pub-id pub-id-type="pmid">23332364</pub-id>
                    <issn>1474-4422</issn>
                </mixed-citation>
            </ref>
            <ref id="b13">
                <label>13. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Varrone</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Asenbaum</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Vander Borght</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Booij</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Nobili</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <name>
                            <surname>Någren</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>European Association of Nuclear Medicine Neuroimaging Committee</collab>
                    </person-group>. 
                    <article-title>EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2</article-title>. 
                    <source>Eur J Nucl Med Mol Imaging</source>. 
                    <year>2009</year>
                    <month>Dec</month>;
                    <volume>36</volume>(
                    <issue>12</issue>):
                    <fpage>2103</fpage>–
                    <lpage>10</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/s00259-009-1264-0</pub-id>
                    <pub-id pub-id-type="pmid">19838705</pub-id>
                    <issn>1619-7070</issn>
                </mixed-citation>
            </ref>
            <ref id="b14">
                <label>14. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Antonini</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>DeNotaris</surname>
                            <given-names>R</given-names>
                        </name>
                    </person-group>. 
                    <article-title>PET and SPECT functional imaging in Parkinson’s disease</article-title>. 
                    <source>Sleep Med</source>. 
                    <year>2004</year>
                    <month>Mar</month>;
                    <volume>5</volume>(
                    <issue>2</issue>):
                    <fpage>201</fpage>–
                    <lpage>6</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.sleep.2003.10.013</pub-id>
                    <pub-id pub-id-type="pmid">15033144</pub-id>
                    <issn>1389-9457</issn>
                </mixed-citation>
            </ref>
            <ref id="b15">
                <label>15. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Stoessl</surname>
                            <given-names>AJ</given-names>
                        </name>, 
                        <name>
                            <surname>Martin</surname>
                            <given-names>WW</given-names>
                        </name>, 
                        <name>
                            <surname>McKeown</surname>
                            <given-names>MJ</given-names>
                        </name>, 
                        <name>
                            <surname>Sossi</surname>
                            <given-names>V</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Advances in imaging in Parkinson’s disease</article-title>. 
                    <source>Lancet Neurol</source>. 
                    <year>2011</year>
                    <month>Nov</month>;
                    <volume>10</volume>(
                    <issue>11</issue>):
                    <fpage>987</fpage>–
                    <lpage>1001</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S1474-4422(11)70214-9</pub-id>
                    <pub-id pub-id-type="pmid">22014434</pub-id>
                    <issn>1474-4422</issn>
                </mixed-citation>
            </ref>
            <ref id="b16">
                <label>16. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Wenning</surname>
                            <given-names>GK</given-names>
                        </name>, 
                        <name>
                            <surname>Donnemiller</surname>
                            <given-names>E</given-names>
                        </name>, 
                        <name>
                            <surname>Granata</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Riccabona</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Poewe</surname>
                            <given-names>W</given-names>
                        </name>
                    </person-group>. 
                    <article-title>
                        <sup>123</sup>I-β-CIT and 
                        <sup>123</sup>I-IBZM-SPECT scanning in levodopa-naive Parkinson’s disease
                    </article-title>. 
                    <source>Mov Disord</source>. 
                    <year>1998</year>
                    <month>May</month>;
                    <volume>13</volume>(
                    <issue>3</issue>):
                    <fpage>438</fpage>–
                    <lpage>45</lpage>. 
                    <pub-id pub-id-type="doi">10.1002/mds.870130311</pub-id>
                    <pub-id pub-id-type="pmid">9613734</pub-id>
                    <issn>0885-3185</issn>
                </mixed-citation>
            </ref>
            <ref id="b17">
                <label>17. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Hellwig</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Amtage</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <name>
                            <surname>Kreft</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Buchert</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Winz</surname>
                            <given-names>OH</given-names>
                        </name>, 
                        <name>
                            <surname>Vach</surname>
                            <given-names>W</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>[¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism</article-title>. 
                    <source>Neurology</source>. 
                    <year>2012</year>
                    <month>Sep</month>;
                    <volume>79</volume>(
                    <issue>13</issue>):
                    <fpage>1314</fpage>–
                    <lpage>22</lpage>. 
                    <pub-id pub-id-type="doi">10.1212/WNL.0b013e31826c1b0a</pub-id>
                    <pub-id pub-id-type="pmid">22914831</pub-id>
                    <issn>0028-3878</issn>
                </mixed-citation>
            </ref>
            <ref id="b18">
                <label>18. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Villemagne</surname>
                            <given-names>VL</given-names>
                        </name>, 
                        <name>
                            <surname>Fodero-Tavoletti</surname>
                            <given-names>MT</given-names>
                        </name>, 
                        <name>
                            <surname>Masters</surname>
                            <given-names>CL</given-names>
                        </name>, 
                        <name>
                            <surname>Rowe</surname>
                            <given-names>CC</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Tau imaging: early progress and future directions</article-title>. 
                    <source>Lancet Neurol</source>. 
                    <year>2015</year>
                    <month>Jan</month>;
                    <volume>14</volume>(
                    <issue>1</issue>):
                    <fpage>114</fpage>–
                    <lpage>24</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S1474-4422(14)70252-2</pub-id>
                    <pub-id pub-id-type="pmid">25496902</pub-id>
                    <issn>1474-4422</issn>
                </mixed-citation>
            </ref>
            <ref id="b19">
                <label>19. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Klunk</surname>
                            <given-names>WE</given-names>
                        </name>, 
                        <name>
                            <surname>Engler</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Nordberg</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Wang</surname>
                            <given-names>Y</given-names>
                        </name>, 
                        <name>
                            <surname>Blomqvist</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Holt</surname>
                            <given-names>DP</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B</article-title>. 
                    <source>Ann Neurol</source>. 
                    <year>2004</year>
                    <month>Mar</month>;
                    <volume>55</volume>(
                    <issue>3</issue>):
                    <fpage>306</fpage>–
                    <lpage>19</lpage>. 
                    <pub-id pub-id-type="doi">10.1002/ana.20009</pub-id>
                    <pub-id pub-id-type="pmid">14991808</pub-id>
                    <issn>0364-5134</issn>
                </mixed-citation>
            </ref>
            <ref id="b20">
                <label>20. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Clark</surname>
                            <given-names>CM</given-names>
                        </name>, 
                        <name>
                            <surname>Schneider</surname>
                            <given-names>JA</given-names>
                        </name>, 
                        <name>
                            <surname>Bedell</surname>
                            <given-names>BJ</given-names>
                        </name>, 
                        <name>
                            <surname>Beach</surname>
                            <given-names>TG</given-names>
                        </name>, 
                        <name>
                            <surname>Bilker</surname>
                            <given-names>WB</given-names>
                        </name>, 
                        <name>
                            <surname>Mintun</surname>
                            <given-names>MA</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>AV45-A07 Study Group</collab>
                    </person-group>. 
                    <article-title>Use of florbetapir-PET for imaging β-amyloid pathology</article-title>. 
                    <source>JAMA</source>. 
                    <year>2011</year>
                    <month>Jan</month>;
                    <volume>305</volume>(
                    <issue>3</issue>):
                    <fpage>275</fpage>–
                    <lpage>83</lpage>. 
                    <pub-id pub-id-type="doi">10.1001/jama.2010.2008</pub-id>
                    <pub-id pub-id-type="pmid">21245183</pub-id>
                    <issn>0098-7484</issn>
                </mixed-citation>
            </ref>
            <ref id="b21">
                <label>21. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Sabri</surname>
                            <given-names>O</given-names>
                        </name>, 
                        <name>
                            <surname>Sabbagh</surname>
                            <given-names>MN</given-names>
                        </name>, 
                        <name>
                            <surname>Seibyl</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Barthel</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Akatsu</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Ouchi</surname>
                            <given-names>Y</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>Florbetaben Phase 3 Study Group</collab>
                    </person-group>. 
                    <article-title>Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer’s disease: phase 3 study</article-title>. 
                    <source>Alzheimers Dement</source>. 
                    <year>2015</year>
                    <month>Aug</month>;
                    <volume>11</volume>(
                    <issue>8</issue>):
                    <fpage>964</fpage>–
                    <lpage>74</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jalz.2015.02.004</pub-id>
                    <pub-id pub-id-type="pmid">25824567</pub-id>
                    <issn>1552-5260</issn>
                </mixed-citation>
            </ref>
            <ref id="b22">
                <label>22. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Wolk</surname>
                            <given-names>DA</given-names>
                        </name>, 
                        <name>
                            <surname>Grachev</surname>
                            <given-names>ID</given-names>
                        </name>, 
                        <name>
                            <surname>Buckley</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Kazi</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Grady</surname>
                            <given-names>MS</given-names>
                        </name>, 
                        <name>
                            <surname>Trojanowski</surname>
                            <given-names>JQ</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology</article-title>. 
                    <source>Arch Neurol</source>. 
                    <year>2011</year>
                    <month>Nov</month>;
                    <volume>68</volume>(
                    <issue>11</issue>):
                    <fpage>1398</fpage>–
                    <lpage>403</lpage>. 
                    <pub-id pub-id-type="doi">10.1001/archneurol.2011.153</pub-id>
                    <pub-id pub-id-type="pmid">21747004</pub-id>
                    <issn>0003-9942</issn>
                </mixed-citation>
            </ref>
            <ref id="b23">
                <label>23. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Mathis</surname>
                            <given-names>CA</given-names>
                        </name>, 
                        <name>
                            <surname>Lopresti</surname>
                            <given-names>BJ</given-names>
                        </name>, 
                        <name>
                            <surname>Ikonomovic</surname>
                            <given-names>MD</given-names>
                        </name>, 
                        <name>
                            <surname>Klunk</surname>
                            <given-names>WE</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Small-molecule PET Tracers for Imaging Proteinopathies</article-title>. 
                    <source>Semin Nucl Med</source>. 
                    <year>2017</year>
                    <month>Sep</month>;
                    <volume>47</volume>(
                    <issue>5</issue>):
                    <fpage>553</fpage>–
                    <lpage>75</lpage>. 
                    <pub-id pub-id-type="doi">10.1053/j.semnuclmed.2017.06.003</pub-id>
                    <pub-id pub-id-type="pmid">28826526</pub-id>
                    <issn>0001-2998</issn>
                </mixed-citation>
            </ref>
            <ref id="b24">
                <label>24. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Bagchi</surname>
                            <given-names>DP</given-names>
                        </name>, 
                        <name>
                            <surname>Yu</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Perlmutter</surname>
                            <given-names>JS</given-names>
                        </name>, 
                        <name>
                            <surname>Xu</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Mach</surname>
                            <given-names>RH</given-names>
                        </name>, 
                        <name>
                            <surname>Tu</surname>
                            <given-names>Z</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Binding of the Radioligand SIL23 to α-Synuclein Fibrils in Parkinson Disease Brain Tissue Establishes Feasibility and Screening Approaches for Developing a Parkinson Disease Imaging Agent</article-title>. 
                    <source>Plos One</source>. 
                    <year>2013</year>;
                    <volume>8</volume>(
                    <issue>2</issue>):
                    <fpage>e55031</fpage>.
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0055031</pub-id>
                    <pub-id pub-id-type="pmid">23405108</pub-id>
                    <issn>1932-6203</issn>
                </mixed-citation>
            </ref>
            <ref id="b25">
                <label>25. </label>
                <mixed-citation publication-type="book">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Friston</surname>
                            <given-names>KJ</given-names>
                        </name>, 
                        <name>
                            <surname>Ashburner</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Kiebel</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Nichols</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Penny</surname>
                            <given-names>WD</given-names>
                        </name>
                    </person-group>. 
                    <source>Statistical parametric mapping: the analysis of funtional brain images</source>. 
                    <publisher-loc>Cambridge</publisher-loc>:
                    <publisher-name>Academic Press</publisher-name>; 
                    <year>2007</year>. 
                    <pub-id pub-id-type="doi">10.1016/B978-012372560-8/50002-4</pub-id>
                </mixed-citation>
            </ref>
            <ref id="b26">
                <label>26. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Minoshima</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Frey</surname>
                            <given-names>KA</given-names>
                        </name>, 
                        <name>
                            <surname>Koeppe</surname>
                            <given-names>RA</given-names>
                        </name>, 
                        <name>
                            <surname>Foster</surname>
                            <given-names>NL</given-names>
                        </name>, 
                        <name>
                            <surname>Kuhl</surname>
                            <given-names>DE</given-names>
                        </name>
                    </person-group>. 
                    <article-title>A diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET</article-title>. 
                    <source>J Nucl Med</source>. 
                    <year>1995</year>
                    <month>Jul</month>;
                    <volume>36</volume>(
                    <issue>7</issue>):
                    <fpage>1238</fpage>–
                    <lpage>48</lpage>.
                    <pub-id pub-id-type="pmid">7790950</pub-id>
                    <issn>0161-5505</issn>
                </mixed-citation>
            </ref>
            <ref id="b27">
                <label>27. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Spetsieris</surname>
                            <given-names>PG</given-names>
                        </name>, 
                        <name>
                            <surname>Ma</surname>
                            <given-names>Y</given-names>
                        </name>, 
                        <name>
                            <surname>Dhawan</surname>
                            <given-names>V</given-names>
                        </name>, 
                        <name>
                            <surname>Eidelberg</surname>
                            <given-names>D</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features</article-title>. 
                    <source>Neuroimage</source>. 
                    <year>2009</year>
                    <month>May</month>;
                    <volume>45</volume>(
                    <issue>4</issue>):
                    <fpage>1241</fpage>–
                    <lpage>52</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.neuroimage.2008.12.063</pub-id>
                    <pub-id pub-id-type="pmid">19349238</pub-id>
                    <issn>1053-8119</issn>
                </mixed-citation>
            </ref>
            <ref id="b28">
                <label>28. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tang</surname>
                            <given-names>CC</given-names>
                        </name>, 
                        <name>
                            <surname>Poston</surname>
                            <given-names>KL</given-names>
                        </name>, 
                        <name>
                            <surname>Eckert</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Feigin</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Frucht</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Gudesblatt</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis</article-title>. 
                    <source>Lancet Neurol</source>. 
                    <year>2010</year>
                    <month>Feb</month>;
                    <volume>9</volume>(
                    <issue>2</issue>):
                    <fpage>149</fpage>–
                    <lpage>58</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S1474-4422(10)70002-8</pub-id>
                    <pub-id pub-id-type="pmid">20061183</pub-id>
                    <issn>1474-4422</issn>
                </mixed-citation>
            </ref>
            <ref id="b29">
                <label>29. </label>
                <mixed-citation publication-type="webpage">
                    <person-group><name><surname></surname></name></person-group>.
                    <source>Strategija obvladovanja demence v Sloveniji do leta 2020</source>. 
                    <comment>Available from:<uri>https://www.gov.si/assets/ministrstva/MZ/DOKUMENTI/Preventiva-in-skrb-za-zdravje/nenalezljive-bolezni/Strategija_obvladovanja_demence.pdf</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b30">
                <label>30. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Ishii</surname>
                            <given-names>K</given-names>
                        </name>
                    </person-group>. 
                    <article-title>PET approaches for diagnosis of dementia</article-title>. 
                    <source>AJNR Am J Neuroradiol</source>. 
                    <year>2014</year>
                    <month>Nov-Dec</month>;
                    <volume>35</volume>(
                    <issue>11</issue>):
                    <fpage>2030</fpage>–
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.3174/ajnr.A3695</pub-id>
                    <pub-id pub-id-type="pmid">23945233</pub-id>
                    <issn>0195-6108</issn>
                </mixed-citation>
            </ref>
            <ref id="b31">
                <label>31. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Minoshima</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Giordani</surname>
                            <given-names>B</given-names>
                        </name>, 
                        <name>
                            <surname>Berent</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Frey</surname>
                            <given-names>KA</given-names>
                        </name>, 
                        <name>
                            <surname>Foster</surname>
                            <given-names>NL</given-names>
                        </name>, 
                        <name>
                            <surname>Kuhl</surname>
                            <given-names>DE</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease</article-title>. 
                    <source>Ann Neurol</source>. 
                    <year>1997</year>
                    <month>Jul</month>;
                    <volume>42</volume>(
                    <issue>1</issue>):
                    <fpage>85</fpage>–
                    <lpage>94</lpage>. 
                    <pub-id pub-id-type="doi">10.1002/ana.410420114</pub-id>
                    <pub-id pub-id-type="pmid">9225689</pub-id>
                    <issn>0364-5134</issn>
                </mixed-citation>
            </ref>
            <ref id="b32">
                <label>32. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Mosconi</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Tsui</surname>
                            <given-names>WH</given-names>
                        </name>, 
                        <name>
                            <surname>Herholz</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Pupi</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Drzezga</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Lucignani</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer’s disease, and other dementias</article-title>. 
                    <source>J Nucl Med</source>. 
                    <year>2008</year>
                    <month>Mar</month>;
                    <volume>49</volume>(
                    <issue>3</issue>):
                    <fpage>390</fpage>–
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.2967/jnumed.107.045385</pub-id>
                    <pub-id pub-id-type="pmid">18287270</pub-id>
                    <issn>0161-5505</issn>
                </mixed-citation>
            </ref>
            <ref id="b33">
                <label>33. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Drzezga</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Grimmer</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Riemenschneider</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Lautenschlager</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Siebner</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Alexopoulus</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET</article-title>. 
                    <source>J Nucl Med</source>. 
                    <year>2005</year>
                    <month>Oct</month>;
                    <volume>46</volume>(
                    <issue>10</issue>):
                    <fpage>1625</fpage>–
                    <lpage>32</lpage>.
                    <pub-id pub-id-type="pmid">16204712</pub-id>
                    <issn>0161-5505</issn>
                </mixed-citation>
            </ref>
            <ref id="b34">
                <label>34. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Whitwell</surname>
                            <given-names>JL</given-names>
                        </name>, 
                        <name>
                            <surname>Graff-Radford</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Singh</surname>
                            <given-names>TD</given-names>
                        </name>, 
                        <name>
                            <surname>Drubach</surname>
                            <given-names>DA</given-names>
                        </name>, 
                        <name>
                            <surname>Senjem</surname>
                            <given-names>ML</given-names>
                        </name>, 
                        <name>
                            <surname>Spychalla</surname>
                            <given-names>AJ</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>
                        <sup>18</sup>F-FDG PET in Posterior Cortical Atrophy and Dementia with Lewy Bodies
                    </article-title>. 
                    <source>J Nucl Med</source>. 
                    <year>2017</year>
                    <month>Apr</month>;
                    <volume>58</volume>(
                    <issue>4</issue>):
                    <fpage>632</fpage>–
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.2967/jnumed.116.179903</pub-id>
                    <pub-id pub-id-type="pmid">27688479</pub-id>
                    <issn>0161-5505</issn>
                </mixed-citation>
            </ref>
            <ref id="b35">
                <label>35. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Papathanasiou</surname>
                            <given-names>ND</given-names>
                        </name>, 
                        <name>
                            <surname>Boutsiadis</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Dickson</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Bomanji</surname>
                            <given-names>JB</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Diagnostic accuracy of ¹²³I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies</article-title>. 
                    <source>Parkinsonism Relat Disord</source>. 
                    <year>2012</year>
                    <month>Mar</month>;
                    <volume>18</volume>(
                    <issue>3</issue>):
                    <fpage>225</fpage>–
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.parkreldis.2011.09.015</pub-id>
                    <pub-id pub-id-type="pmid">21975260</pub-id>
                    <issn>1353-8020</issn>
                </mixed-citation>
            </ref>
            <ref id="b36">
                <label>36. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>McKeith</surname>
                            <given-names>IG</given-names>
                        </name>, 
                        <name>
                            <surname>Boeve</surname>
                            <given-names>BF</given-names>
                        </name>, 
                        <name>
                            <surname>Dickson</surname>
                            <given-names>DW</given-names>
                        </name>, 
                        <name>
                            <surname>Halliday</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Taylor</surname>
                            <given-names>JP</given-names>
                        </name>, 
                        <name>
                            <surname>Weintraub</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium</article-title>. 
                    <source>Neurology</source>. 
                    <year>2017</year>
                    <month>Jul</month>;
                    <volume>89</volume>(
                    <issue>1</issue>):
                    <fpage>88</fpage>–
                    <lpage>100</lpage>. 
                    <pub-id pub-id-type="doi">10.1212/WNL.0000000000004058</pub-id>
                    <pub-id pub-id-type="pmid">28592453</pub-id>
                    <issn>0028-3878</issn>
                </mixed-citation>
            </ref>
            <ref id="b37">
                <label>37. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Cerami</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Dodich</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Greco</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Iannaccone</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Magnani</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Marcone</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia</article-title>. 
                    <source>J Alzheimers Dis</source>. 
                    <year>2017</year>;
                    <volume>55</volume>(
                    <issue>1</issue>):
                    <fpage>183</fpage>–
                    <lpage>97</lpage>. 
                    <pub-id pub-id-type="doi">10.3233/JAD-160682</pub-id>
                    <pub-id pub-id-type="pmid">27662315</pub-id>
                    <issn>1387-2877</issn>
                </mixed-citation>
            </ref>
            <ref id="b38">
                <label>38. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Ishii</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Soma</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Kono</surname>
                            <given-names>AK</given-names>
                        </name>, 
                        <name>
                            <surname>Sofue</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Miyamoto</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Yoshikawa</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Comparison of regional brain volume and glucose metabolism between patients with mild dementia with lewy bodies and those with mild Alzheimer’s disease</article-title>. 
                    <source>J Nucl Med</source>. 
                    <year>2007</year>
                    <month>May</month>;
                    <volume>48</volume>(
                    <issue>5</issue>):
                    <fpage>704</fpage>–
                    <lpage>11</lpage>. 
                    <pub-id pub-id-type="doi">10.2967/jnumed.106.035691</pub-id>
                    <pub-id pub-id-type="pmid">17475957</pub-id>
                    <issn>0161-5505</issn>
                </mixed-citation>
            </ref>
            <ref id="b39">
                <label>39. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Lim</surname>
                            <given-names>SM</given-names>
                        </name>, 
                        <name>
                            <surname>Katsifis</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Villemagne</surname>
                            <given-names>VL</given-names>
                        </name>, 
                        <name>
                            <surname>Best</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Jones</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Saling</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies</article-title>. 
                    <source>J Nucl Med</source>. 
                    <year>2009</year>
                    <month>Oct</month>;
                    <volume>50</volume>(
                    <issue>10</issue>):
                    <fpage>1638</fpage>–
                    <lpage>45</lpage>. 
                    <pub-id pub-id-type="doi">10.2967/jnumed.109.065870</pub-id>
                    <pub-id pub-id-type="pmid">19759102</pub-id>
                    <issn>0161-5505</issn>
                </mixed-citation>
            </ref>
            <ref id="b40">
                <label>40. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Ishii</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Soma</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Kono</surname>
                            <given-names>AK</given-names>
                        </name>, 
                        <name>
                            <surname>Sofue</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Miyamoto</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Yoshikawa</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Comparison of regional brain volume and glucose metabolism between patients with mild dementia with lewy bodies and those with mild Alzheimer’s disease</article-title>. 
                    <source>J Nucl Med</source>. 
                    <year>2007</year>
                    <month>May</month>;
                    <volume>48</volume>(
                    <issue>5</issue>):
                    <fpage>704</fpage>–
                    <lpage>11</lpage>. 
                    <pub-id pub-id-type="doi">10.2967/jnumed.106.035691</pub-id>
                    <pub-id pub-id-type="pmid">17475957</pub-id>
                    <issn>0161-5505</issn>                    
                </mixed-citation>
            </ref>
            <ref id="b41">
                <label>41. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Hely</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Reid</surname>
                            <given-names>W</given-names>
                        </name>, 
                        <name>
                            <surname>Adena</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Halliday</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Morris</surname>
                            <given-names>J</given-names>
                        </name>
                    </person-group>. 
                    <article-title>The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 2008 Apr 30;23(6):837- 844</article-title>. 
                    <source>Mov Disord</source>. 
                    <year>2008</year>
                    <month>Feb</month>;
                    <volume>23</volume>(
                    <issue>6</issue>):
                    <fpage>837</fpage>–
                    <lpage>44</lpage>. 
                    <pub-id pub-id-type="doi">10.1002/mds.21956</pub-id>
                    <pub-id pub-id-type="pmid">18307261</pub-id>
                    <issn>0885-3185</issn>
                </mixed-citation>
            </ref>
            <ref id="b42">
                <label>42. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Yong</surname>
                            <given-names>SW</given-names>
                        </name>, 
                        <name>
                            <surname>Yoon</surname>
                            <given-names>JK</given-names>
                        </name>, 
                        <name>
                            <surname>An</surname>
                            <given-names>YS</given-names>
                        </name>, 
                        <name>
                            <surname>Lee</surname>
                            <given-names>PH</given-names>
                        </name>
                    </person-group>. 
                    <article-title>A comparison of cerebral glucose metabolism in Parkinson’s disease, Parkinson’s disease dementia and dementia with Lewy bodies</article-title>. 
                    <source>Eur J Neurol</source>. 
                    <year>2007</year>
                    <month>Dec</month>;
                    <volume>14</volume>(
                    <issue>12</issue>):
                    <fpage>1357</fpage>–
                    <lpage>62</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1468-1331.2007.01977.x</pub-id>
                    <pub-id pub-id-type="pmid">17941855</pub-id>
                    <issn>1351-5101</issn>
                </mixed-citation>
            </ref>
            <ref id="b43">
                <label>43. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Perneczky</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Diehl-Schmid</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Pohl</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Drzezga</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Kurz</surname>
                            <given-names>A</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Non-fluent progressive aphasia: cerebral metabolic patterns and brain reserve</article-title>. 
                    <source>Brain Res</source>. 
                    <year>2007</year>
                    <month>Feb</month>;
                    <volume>1133</volume>(
                    <issue>1</issue>):
                    <fpage>178</fpage>–
                    <lpage>85</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.brainres.2006.11.054</pub-id>
                    <pub-id pub-id-type="pmid">17184752</pub-id>
                    <issn>0006-8993</issn>
                </mixed-citation>
            </ref>
            <ref id="b44">
                <label>44. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Salmon</surname>
                            <given-names>E</given-names>
                        </name>, 
                        <name>
                            <surname>Garraux</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Delbeuck</surname>
                            <given-names>X</given-names>
                        </name>, 
                        <name>
                            <surname>Collette</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <name>
                            <surname>Kalbe</surname>
                            <given-names>E</given-names>
                        </name>, 
                        <name>
                            <surname>Zuendorf</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Predominant ventromedial frontopolar metabolic impairment in frontotemporal dementia</article-title>. 
                    <source>Neuroimage</source>. 
                    <year>2003</year>
                    <month>Sep</month>;
                    <volume>20</volume>(
                    <issue>1</issue>):
                    <fpage>435</fpage>–
                    <lpage>40</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S1053-8119(03)00346-X</pub-id>
                    <pub-id pub-id-type="pmid">14527604</pub-id>
                    <issn>1053-8119</issn>
                </mixed-citation>
            </ref>
            <ref id="b45">
                <label>45. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Foster</surname>
                            <given-names>NL</given-names>
                        </name>, 
                        <name>
                            <surname>Heidebrink</surname>
                            <given-names>JL</given-names>
                        </name>, 
                        <name>
                            <surname>Clark</surname>
                            <given-names>CM</given-names>
                        </name>, 
                        <name>
                            <surname>Jagust</surname>
                            <given-names>WJ</given-names>
                        </name>, 
                        <name>
                            <surname>Arnold</surname>
                            <given-names>SE</given-names>
                        </name>, 
                        <name>
                            <surname>Barbas</surname>
                            <given-names>NR</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer’s disease</article-title>. 
                    <source>Brain</source>. 
                    <year>2007</year>
                    <month>Oct</month>;
                    <volume>130</volume>(
                    <issue>Pt 10</issue>):
                    <fpage>2616</fpage>–
                    <lpage>35</lpage>. 
                    <pub-id pub-id-type="doi">10.1093/brain/awm177</pub-id>
                    <pub-id pub-id-type="pmid">17704526</pub-id>
                    <issn>0006-8950</issn>
                </mixed-citation>
            </ref>
            <ref id="b46">
                <label>46. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Diehl-Schmid</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Grimmer</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Drzezga</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Bornschein</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Riemenschneider</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Förstl</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study</article-title>. 
                    <source>Neurobiol Aging</source>. 
                    <year>2007</year>
                    <month>Jan</month>;
                    <volume>28</volume>(
                    <issue>1</issue>):
                    <fpage>42</fpage>–
                    <lpage>50</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2005.11.002</pub-id>
                    <pub-id pub-id-type="pmid">16448722</pub-id>
                    <issn>0197-4580</issn>
                </mixed-citation>
            </ref>
            <ref id="b47">
                <label>47. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Desgranges</surname>
                            <given-names>B</given-names>
                        </name>, 
                        <name>
                            <surname>Matuszewski</surname>
                            <given-names>V</given-names>
                        </name>, 
                        <name>
                            <surname>Piolino</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Chételat</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Mézenge</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <name>
                            <surname>Landeau</surname>
                            <given-names>B</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Anatomical and functional alterations in semantic dementia: a voxel-based MRI and PET study</article-title>. 
                    <source>Neurobiol Aging</source>. 
                    <year>2007</year>
                    <month>Dec</month>;
                    <volume>28</volume>(
                    <issue>12</issue>):
                    <fpage>1904</fpage>–
                    <lpage>13</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2006.08.006</pub-id>
                    <pub-id pub-id-type="pmid">16979268</pub-id>
                    <issn>0197-4580</issn>
                </mixed-citation>
            </ref>
            <ref id="b48">
                <label>48. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Kerrouche</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Herholz</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Mielke</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Holthoff</surname>
                            <given-names>V</given-names>
                        </name>, 
                        <name>
                            <surname>Baron</surname>
                            <given-names>JC</given-names>
                        </name>
                    </person-group>. 
                    <article-title>
                        <sup>18</sup>FDG PET in vascular dementia: differentiation from Alzheimer’s disease using voxel-based multivariate analysis
                    </article-title>. 
                    <source>J Cereb Blood Flow Metab</source>. 
                    <year>2006</year>
                    <month>Sep</month>;
                    <volume>26</volume>(
                    <issue>9</issue>):
                    <fpage>1213</fpage>–
                    <lpage>21</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/sj.jcbfm.9600296</pub-id>
                    <pub-id pub-id-type="pmid">16525414</pub-id>
                    <issn>0271-678X</issn>
                </mixed-citation>
            </ref>
            <ref id="b49">
                <label>49. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Heiss</surname>
                            <given-names>WD</given-names>
                        </name>, 
                        <name>
                            <surname>Zimmermann-Meinzingen</surname>
                            <given-names>S</given-names>
                        </name>
                    </person-group>. 
                    <article-title>PET imaging in the differential diagnosis of vascular dementia</article-title>. 
                    <source>J Neurol Sci</source>. 
                    <year>2012</year>
                    <month>Nov</month>;
                    <volume>322</volume>(
                    <issue>1-2</issue>):
                    <fpage>268</fpage>–
                    <lpage>73</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jns.2012.09.023</pub-id>
                    <pub-id pub-id-type="pmid">23043907</pub-id>
                    <issn>0022-510X</issn>
                </mixed-citation>
            </ref>
            <ref id="b50">
                <label>50. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Zerr</surname>
                            <given-names>I</given-names>
                        </name>, 
                        <name>
                            <surname>Kallenberg</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Summers</surname>
                            <given-names>DM</given-names>
                        </name>, 
                        <name>
                            <surname>Romero</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Taratuto</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Heinemann</surname>
                            <given-names>U</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease</article-title>. 
                    <source>Brain</source>. 
                    <year>2009</year>
                    <month>Oct</month>;
                    <volume>132</volume>(
                    <issue>Pt 10</issue>):
                    <fpage>2659</fpage>–
                    <lpage>68</lpage>. 
                    <pub-id pub-id-type="doi">10.1093/brain/awp191</pub-id>
                    <pub-id pub-id-type="pmid">19773352</pub-id>
                    <issn>0006-8950</issn>
                </mixed-citation>
            </ref>
            <ref id="b51">
                <label>51. </label>
                <mixed-citation publication-type="book-chapter">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Rus</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Popović</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Grmek</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Ibrulj</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Zupančič Križnar</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Granda</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <chapter-title>Metabolic Biomarkers of Sporadic Creutzfeldt-Jakob Disease</chapter-title>. In: 
                    <person-group person-group-type="editor">
                        <name>
                            <surname>Gregorič Kramberger</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <role>ed</role>
                    </person-group>.
                    <source>8th Cognitive Day: Dementias and the Role of Fluid Biomarkers</source>.
                    <publisher-loc>Ljubljana</publisher-loc>:
                    <publisher-name>Center for Cognitive Imparements, Department of Neurology, Neurology Clinic, University Medical Centre Ljubljana</publisher-name>;
                    <year>2019</year>.
                </mixed-citation>
            </ref>
            <ref id="b52">
                <label>52. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Masters</surname>
                            <given-names>CL</given-names>
                        </name>, 
                        <name>
                            <surname>Bateman</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Blennow</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Rowe</surname>
                            <given-names>CC</given-names>
                        </name>, 
                        <name>
                            <surname>Sperling</surname>
                            <given-names>RA</given-names>
                        </name>, 
                        <name>
                            <surname>Cummings</surname>
                            <given-names>JL</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Alzheimer’s disease</article-title>. 
                    <source>Nat Rev Dis Primers</source>. 
                    <year>2015</year>
                    <month>Oct</month>;
                    <volume>1</volume>(
                    <issue>1</issue>):
                    <fpage>15056</fpage>. 
                    <pub-id pub-id-type="doi">10.1038/nrdp.2015.56</pub-id>
                    <pub-id pub-id-type="pmid">27188934</pub-id>
                    <issn>2056-676X</issn>
                </mixed-citation>
            </ref>
            <ref id="b53">
                <label>53. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Jack</surname>
                            <given-names>CR</given-names>
                            <suffix>Jr</suffix>
                        </name>, 
                        <name>
                            <surname>Wiste</surname>
                            <given-names>HJ</given-names>
                        </name>, 
                        <name>
                            <surname>Vemuri</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Weigand</surname>
                            <given-names>SD</given-names>
                        </name>, 
                        <name>
                            <surname>Senjem</surname>
                            <given-names>ML</given-names>
                        </name>, 
                        <name>
                            <surname>Zeng</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>Alzheimer’s Disease Neuroimaging Initiative</collab>
                    </person-group>. 
                    <article-title>Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer’s disease</article-title>. 
                    <source>Brain</source>. 
                    <year>2010</year>
                    <month>Nov</month>;
                    <volume>133</volume>(
                    <issue>11</issue>):
                    <fpage>3336</fpage>–
                    <lpage>48</lpage>. 
                    <pub-id pub-id-type="doi">10.1093/brain/awq277</pub-id>
                    <pub-id pub-id-type="pmid">20935035</pub-id>
                    <issn>0006-8950</issn>
                </mixed-citation>
            </ref>
            <ref id="b54">
                <label>54. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Petersen</surname>
                            <given-names>RC</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Alzheimer’s disease: progress in prediction</article-title>. 
                    <source>Lancet Neurol</source>. 
                    <year>2010</year>
                    <month>Jan</month>;
                    <volume>9</volume>(
                    <issue>1</issue>):
                    <fpage>4</fpage>–
                    <lpage>5</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S1474-4422(09)70330-8</pub-id>
                    <pub-id pub-id-type="pmid">20083022</pub-id>
                    <issn>1474-4422</issn>
                </mixed-citation>
            </ref>
            <ref id="b55">
                <label>55. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Skillbäck</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Farahmand</surname>
                            <given-names>BY</given-names>
                        </name>, 
                        <name>
                            <surname>Rosén</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Mattsson</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Nägga</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Kilander</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Cerebrospinal fluid tau and amyloid-β
                        <sub>1-42</sub> in patients with dementia
                    </article-title>. 
                    <source>Brain</source>. 
                    <year>2015</year>
                    <month>Sep</month>;
                    <volume>138</volume>(
                    <issue>Pt 9</issue>):
                    <fpage>2716</fpage>–
                    <lpage>31</lpage>. 
                    <pub-id pub-id-type="doi">10.1093/brain/awv181</pub-id>
                    <pub-id pub-id-type="pmid">26133663</pub-id>
                    <issn>0006-8950</issn>
                </mixed-citation>
            </ref>
            <ref id="b56">
                <label>56. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Duits</surname>
                            <given-names>FH</given-names>
                        </name>, 
                        <name>
                            <surname>Teunissen</surname>
                            <given-names>CE</given-names>
                        </name>, 
                        <name>
                            <surname>Bouwman</surname>
                            <given-names>FH</given-names>
                        </name>, 
                        <name>
                            <surname>Visser</surname>
                            <given-names>PJ</given-names>
                        </name>, 
                        <name>
                            <surname>Mattsson</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Zetterberg</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>The cerebrospinal fluid “Alzheimer profile”: easily said, but what does it mean?</article-title>
                    <source>Alzheimers Dement</source>. 
                    <year>2014</year>
                    <month>Nov</month>;
                    <volume>10</volume>(
                    <issue>6</issue>):
                    <fpage>713</fpage>–
                    <lpage>723.e2</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jalz.2013.12.023</pub-id>
                    <pub-id pub-id-type="pmid">24721526</pub-id>
                    <issn>1552-5260</issn>
                </mixed-citation>
            </ref>
            <ref id="b57">
                <label>57. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Sevigny</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Chiao</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Bussière</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Weinreb</surname>
                            <given-names>PH</given-names>
                        </name>, 
                        <name>
                            <surname>Williams</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Maier</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease</article-title>. 
                    <source>Nature</source>. 
                    <year>2016</year>
                    <month>Sep</month>;
                    <volume>537</volume>(
                    <issue>7618</issue>):
                    <fpage>50</fpage>–
                    <lpage>6</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/nature19323</pub-id>
                    <pub-id pub-id-type="pmid">27582220</pub-id>
                    <issn>0028-0836</issn>
                </mixed-citation>
            </ref>
            <ref id="b58">
                <label>58. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Johnson</surname>
                            <given-names>KA</given-names>
                        </name>, 
                        <name>
                            <surname>Minoshima</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Bohnen</surname>
                            <given-names>NI</given-names>
                        </name>, 
                        <name>
                            <surname>Donohoe</surname>
                            <given-names>KJ</given-names>
                        </name>, 
                        <name>
                            <surname>Foster</surname>
                            <given-names>NL</given-names>
                        </name>, 
                        <name>
                            <surname>Herscovitch</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>Alzheimer’s Association</collab>; 
                        <collab>Society of Nuclear Medicine and Molecular Imaging</collab>; 
                        <collab>Amyloid Imaging Taskforce</collab>
                    </person-group>. 
                    <article-title>Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association</article-title>. 
                    <source>Alzheimers Dement</source>. 
                    <year>2013</year>
                    <month>Jan</month>;
                    <volume>9</volume>(
                    <issue>1</issue>):
                    <fpage>e-1</fpage>–
                    <lpage>16</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.jalz.2013.01.002</pub-id>
                    <pub-id pub-id-type="pmid">23360977</pub-id>
                    <issn>1552-5260</issn>
                </mixed-citation>
            </ref>
            <ref id="b59">
                <label>59. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Minoshima</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Drzezga</surname>
                            <given-names>AE</given-names>
                        </name>, 
                        <name>
                            <surname>Barthel</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Bohnen</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Djekidel</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Lewis</surname>
                            <given-names>DH</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0</article-title>. 
                    <source>J Nucl Med</source>. 
                    <year>2016</year>
                    <month>Aug</month>;
                    <volume>57</volume>(
                    <issue>8</issue>):
                    <fpage>1316</fpage>–
                    <lpage>22</lpage>. 
                    <pub-id pub-id-type="doi">10.2967/jnumed.116.174615</pub-id>
                    <pub-id pub-id-type="pmid">27481605</pub-id>
                    <issn>0161-5505</issn>
                </mixed-citation>
            </ref>
            <ref id="b60">
                <label>60. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Villemagne</surname>
                            <given-names>VL</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Amyloid imaging: Past, present and future perspectives</article-title>. 
                    <source>Ageing Res Rev</source>. 
                    <year>2016</year>
                    <month>Sep</month>;
                    <volume>30</volume>:
                    <fpage>95</fpage>–
                    <lpage>106</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.arr.2016.01.005</pub-id>
                    <pub-id pub-id-type="pmid">26827784</pub-id>
                    <issn>1568-1637</issn>
                </mixed-citation>
            </ref>
            <ref id="b61">
                <label>61. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Clark</surname>
                            <given-names>CM</given-names>
                        </name>, 
                        <name>
                            <surname>Pontecorvo</surname>
                            <given-names>MJ</given-names>
                        </name>, 
                        <name>
                            <surname>Beach</surname>
                            <given-names>TG</given-names>
                        </name>, 
                        <name>
                            <surname>Bedell</surname>
                            <given-names>BJ</given-names>
                        </name>, 
                        <name>
                            <surname>Coleman</surname>
                            <given-names>RE</given-names>
                        </name>, 
                        <name>
                            <surname>Doraiswamy</surname>
                            <given-names>PM</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>AV-45-A16 Study Group</collab>
                    </person-group>. 
                    <article-title>Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study</article-title>. 
                    <source>Lancet Neurol</source>. 
                    <year>2012</year>
                    <month>Aug</month>;
                    <volume>11</volume>(
                    <issue>8</issue>):
                    <fpage>669</fpage>–
                    <lpage>78</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S1474-4422(12)70142-4</pub-id>
                    <pub-id pub-id-type="pmid">22749065</pub-id>
                    <issn>1474-4422</issn>
                </mixed-citation>
            </ref>
            <ref id="b62">
                <label>62. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Charidimou</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Farid</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Tsai</surname>
                            <given-names>HH</given-names>
                        </name>, 
                        <name>
                            <surname>Tsai</surname>
                            <given-names>LK</given-names>
                        </name>, 
                        <name>
                            <surname>Yen</surname>
                            <given-names>RF</given-names>
                        </name>, 
                        <name>
                            <surname>Baron</surname>
                            <given-names>JC</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Amyloid-PET burden and regional distribution in cerebral amyloid angiopathy: a systematic review and meta-analysis of biomarker performance</article-title>. 
                    <source>J Neurol Neurosurg Psychiatry</source>. 
                    <year>2018</year>
                    <month>Apr</month>;
                    <volume>89</volume>(
                    <issue>4</issue>):
                    <fpage>410</fpage>–
                    <lpage>7</lpage>. 
                    <pub-id pub-id-type="doi">10.1136/jnnp-2017-316851</pub-id>
                    <pub-id pub-id-type="pmid">29070646</pub-id>
                    <issn>0022-3050</issn>
                </mixed-citation>
            </ref>
            <ref id="b63">
                <label>63. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Kantarci</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Lowe</surname>
                            <given-names>VJ</given-names>
                        </name>, 
                        <name>
                            <surname>Boeve</surname>
                            <given-names>BF</given-names>
                        </name>, 
                        <name>
                            <surname>Senjem</surname>
                            <given-names>ML</given-names>
                        </name>, 
                        <name>
                            <surname>Tosakulwong</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Lesnick</surname>
                            <given-names>TG</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies</article-title>. 
                    <source>Ann Neurol</source>. 
                    <year>2017</year>
                    <month>Jan</month>;
                    <volume>81</volume>(
                    <issue>1</issue>):
                    <fpage>58</fpage>–
                    <lpage>67</lpage>. 
                    <pub-id pub-id-type="doi">10.1002/ana.24825</pub-id>
                    <pub-id pub-id-type="pmid">27863444</pub-id>
                    <issn>0364-5134</issn>
                </mixed-citation>
            </ref>
            <ref id="b64">
                <label>64. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Postuma</surname>
                            <given-names>RB</given-names>
                        </name>, 
                        <name>
                            <surname>Berg</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Stern</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Poewe</surname>
                            <given-names>W</given-names>
                        </name>, 
                        <name>
                            <surname>Olanow</surname>
                            <given-names>CW</given-names>
                        </name>, 
                        <name>
                            <surname>Oertel</surname>
                            <given-names>W</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>MDS clinical diagnostic criteria for Parkinson’s disease</article-title>. 
                    <source>Mov Disord</source>. 
                    <year>2015</year>
                    <month>Oct</month>;
                    <volume>30</volume>(
                    <issue>12</issue>):
                    <fpage>1591</fpage>–
                    <lpage>601</lpage>. 
                    <pub-id pub-id-type="doi">10.1002/mds.26424</pub-id>
                    <pub-id pub-id-type="pmid">26474316</pub-id>
                    <issn>0885-3185</issn>
                </mixed-citation>
            </ref>
            <ref id="b65">
                <label>65. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Gilman</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Wenning</surname>
                            <given-names>GK</given-names>
                        </name>, 
                        <name>
                            <surname>Low</surname>
                            <given-names>PA</given-names>
                        </name>, 
                        <name>
                            <surname>Brooks</surname>
                            <given-names>DJ</given-names>
                        </name>, 
                        <name>
                            <surname>Mathias</surname>
                            <given-names>CJ</given-names>
                        </name>, 
                        <name>
                            <surname>Trojanowski</surname>
                            <given-names>JQ</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Second consensus statement on the diagnosis of multiple system atrophy</article-title>. 
                    <source>Neurology</source>. 
                    <year>2008</year>
                    <month>Aug</month>;
                    <volume>71</volume>(
                    <issue>9</issue>):
                    <fpage>670</fpage>–
                    <lpage>6</lpage>. 
                    <pub-id pub-id-type="doi">10.1212/01.wnl.0000324625.00404.15</pub-id>
                    <pub-id pub-id-type="pmid">18725592</pub-id>
                    <issn>0028-3878</issn>
                </mixed-citation>
            </ref>
            <ref id="b66">
                <label>66. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Litvan</surname>
                            <given-names>I</given-names>
                        </name>, 
                        <name>
                            <surname>Agid</surname>
                            <given-names>Y</given-names>
                        </name>, 
                        <name>
                            <surname>Calne</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Campbell</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Dubois</surname>
                            <given-names>B</given-names>
                        </name>, 
                        <name>
                            <surname>Duvoisin</surname>
                            <given-names>RC</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop</article-title>. 
                    <source>Neurology</source>. 
                    <year>1996</year>
                    <month>Jul</month>;
                    <volume>47</volume>(
                    <issue>1</issue>):
                    <fpage>1</fpage>–
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1212/WNL.47.1.1</pub-id>
                    <pub-id pub-id-type="pmid">8710059</pub-id>
                    <issn>0028-3878</issn>
                </mixed-citation>
            </ref>
            <ref id="b67">
                <label>67. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Armstrong</surname>
                            <given-names>MJ</given-names>
                        </name>, 
                        <name>
                            <surname>Litvan</surname>
                            <given-names>I</given-names>
                        </name>, 
                        <name>
                            <surname>Lang</surname>
                            <given-names>AE</given-names>
                        </name>, 
                        <name>
                            <surname>Bak</surname>
                            <given-names>TH</given-names>
                        </name>, 
                        <name>
                            <surname>Bhatia</surname>
                            <given-names>KP</given-names>
                        </name>, 
                        <name>
                            <surname>Borroni</surname>
                            <given-names>B</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Criteria for the diagnosis of corticobasal degeneration</article-title>. 
                    <source>Neurology</source>. 
                    <year>2013</year>
                    <month>Jan</month>;
                    <volume>80</volume>(
                    <issue>5</issue>):
                    <fpage>496</fpage>–
                    <lpage>503</lpage>. 
                    <pub-id pub-id-type="doi">10.1212/WNL.0b013e31827f0fd1</pub-id>
                    <pub-id pub-id-type="pmid">23359374</pub-id>
                    <issn>0028-3878</issn>
                </mixed-citation>
            </ref>
            <ref id="b68">
                <label>68. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Isaacson</surname>
                            <given-names>SH</given-names>
                        </name>, 
                        <name>
                            <surname>Fisher</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Gupta</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <name>
                            <surname>Hermanowicz</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Kremens</surname>
                            <given-names>DE</given-names>
                        </name>, 
                        <name>
                            <surname>Lew</surname>
                            <given-names>MF</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective</article-title>. 
                    <source>Expert Rev Neurother</source>. 
                    <year>2017</year>
                    <month>Mar</month>;
                    <volume>17</volume>(
                    <issue>3</issue>):
                    <fpage>219</fpage>–
                    <lpage>25</lpage>. 
                    <pub-id pub-id-type="doi">10.1080/14737175.2017.1256205</pub-id>
                    <pub-id pub-id-type="pmid">27813429</pub-id>
                    <issn>1473-7175</issn>
                </mixed-citation>
            </ref>
            <ref id="b69">
                <label>69. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Flisar</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Puklavec</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Grmek</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Trošt</surname>
                            <given-names>M</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Slikanje SPECT dopaminskega prenašalca pri boleznih možganov</article-title>. 
                    <source>Zdr Vestn</source>. 
                    <year>2008</year>
                    <month>Sep</month>;
                    <volume>77</volume>:
                    <fpage>635</fpage>–
                    <lpage>40</lpage>.
                    <issn>1318-0347</issn>
                </mixed-citation>
            </ref>
            <ref id="b70">
                <label>70. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Hauser</surname>
                            <given-names>RA</given-names>
                        </name>, 
                        <name>
                            <surname>Grosset</surname>
                            <given-names>DG</given-names>
                        </name>
                    </person-group>. 
                    <article-title>[123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes</article-title>. 
                    <source>J Neuroimaging</source>. 
                    <year>2012</year>
                    <month>Jul</month>;
                    <volume>22</volume>(
                    <issue>3</issue>):
                    <fpage>225</fpage>–
                    <lpage>30</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1552-6569.2011.00583.x</pub-id>
                    <pub-id pub-id-type="pmid">21410815</pub-id>
                    <issn>1051-2284</issn>
                </mixed-citation>
            </ref>
            <ref id="b71">
                <label>71. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Darcourt</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Booij</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Tatsch</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Varrone</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Vander Borght</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Kapucu</surname>
                            <given-names>ÖL</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2</article-title>. 
                    <source>Eur J Nucl Med Mol Imaging</source>. 
                    <year>2010</year>
                    <month>Feb</month>;
                    <volume>37</volume>(
                    <issue>2</issue>):
                    <fpage>443</fpage>–
                    <lpage>50</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/s00259-009-1267-x</pub-id>
                    <pub-id pub-id-type="pmid">19838702</pub-id>
                    <issn>1619-7070</issn>
                </mixed-citation>
            </ref>
            <ref id="b72">
                <label>72. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Brooks</surname>
                            <given-names>DJ</given-names>
                        </name>, 
                        <name>
                            <surname>Pavese</surname>
                            <given-names>N</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Imaging biomarkers in Parkinson’s disease</article-title>. 
                    <source>Prog Neurobiol</source>. 
                    <year>2011</year>
                    <month>Dec</month>;
                    <volume>95</volume>(
                    <issue>4</issue>):
                    <fpage>614</fpage>–
                    <lpage>28</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.pneurobio.2011.08.009</pub-id>
                    <pub-id pub-id-type="pmid">21896306</pub-id>
                    <issn>0301-0082</issn>
                </mixed-citation>
            </ref>
            <ref id="b73">
                <label>73. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Borghammer</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Chakravarty</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Jonsdottir</surname>
                            <given-names>KY</given-names>
                        </name>, 
                        <name>
                            <surname>Sato</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Matsuda</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Ito</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: probably even at early disease stages</article-title>. 
                    <source>Brain Struct Funct</source>. 
                    <year>2010</year>
                    <month>May</month>;
                    <volume>214</volume>(
                    <issue>4</issue>):
                    <fpage>303</fpage>–
                    <lpage>17</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/s00429-010-0246-0</pub-id>
                    <pub-id pub-id-type="pmid">20361208</pub-id>
                    <issn>1863-2653</issn>
                </mixed-citation>
            </ref>
            <ref id="b74">
                <label>74. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Ma</surname>
                            <given-names>Y</given-names>
                        </name>, 
                        <name>
                            <surname>Tang</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Spetsieris</surname>
                            <given-names>PG</given-names>
                        </name>, 
                        <name>
                            <surname>Dhawan</surname>
                            <given-names>V</given-names>
                        </name>, 
                        <name>
                            <surname>Eidelberg</surname>
                            <given-names>D</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Abnormal metabolic network activity in Parkinson’s disease: test-retest reproducibility</article-title>. 
                    <source>J Cereb Blood Flow Metab</source>. 
                    <year>2007</year>
                    <month>Mar</month>;
                    <volume>27</volume>(
                    <issue>3</issue>):
                    <fpage>597</fpage>–
                    <lpage>605</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/sj.jcbfm.9600358</pub-id>
                    <pub-id pub-id-type="pmid">16804550</pub-id>
                    <issn>0271-678X</issn>
                </mixed-citation>
            </ref>
            <ref id="b75">
                <label>75. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tomše</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Jensterle</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Grmek</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Zaletel</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Pirtošek</surname>
                            <given-names>Z</given-names>
                        </name>, 
                        <name>
                            <surname>Dhawan</surname>
                            <given-names>V</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Abnormal metabolic brain network associated with Parkinson’s disease: replication on a new European sample</article-title>. 
                    <source>Neuroradiology</source>. 
                    <year>2017</year>
                    <month>May</month>;
                    <volume>59</volume>(
                    <issue>5</issue>):
                    <fpage>507</fpage>–
                    <lpage>15</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/s00234-017-1821-3</pub-id>
                    <pub-id pub-id-type="pmid">28386687</pub-id>
                    <issn>0028-3940</issn>
                </mixed-citation>
            </ref>
            <ref id="b76">
                <label>76. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Taniwaki</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Nakagawa</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Yamada</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Yoshida</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Ohyagi</surname>
                            <given-names>Y</given-names>
                        </name>, 
                        <name>
                            <surname>Sasaki</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Cerebral metabolic changes in early multiple system atrophy: a PET study</article-title>. 
                    <source>J Neurol Sci</source>. 
                    <year>2002</year>
                    <month>Aug</month>;
                    <volume>200</volume>(
                    <issue>1-2</issue>):
                    <fpage>79</fpage>–
                    <lpage>84</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S0022-510X(02)00151-X</pub-id>
                    <pub-id pub-id-type="pmid">12127681</pub-id>
                    <issn>0022-510X</issn>
                </mixed-citation>
            </ref>
            <ref id="b77">
                <label>77. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Eckert</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Barnes</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Dhawan</surname>
                            <given-names>V</given-names>
                        </name>, 
                        <name>
                            <surname>Frucht</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Gordon</surname>
                            <given-names>MF</given-names>
                        </name>, 
                        <name>
                            <surname>Feigin</surname>
                            <given-names>AS</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>FDG PET in the differential diagnosis of parkinsonian disorders</article-title>. 
                    <source>Neuroimage</source>. 
                    <year>2005</year>
                    <month>Jul</month>;
                    <volume>26</volume>(
                    <issue>3</issue>):
                    <fpage>912</fpage>–
                    <lpage>21</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.neuroimage.2005.03.012</pub-id>
                    <pub-id pub-id-type="pmid">15955501</pub-id>
                    <issn>1053-8119</issn>
                </mixed-citation>
            </ref>
            <ref id="b78">
                <label>78. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Niccolini</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <name>
                            <surname>Politis</surname>
                            <given-names>M</given-names>
                        </name>
                    </person-group>. 
                    <article-title>A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism</article-title>. 
                    <source>Eur J Nucl Med Mol Imaging</source>. 
                    <year>2016</year>
                    <month>Nov</month>;
                    <volume>43</volume>(
                    <issue>12</issue>):
                    <fpage>2244</fpage>–
                    <lpage>54</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/s00259-016-3464-8</pub-id>
                    <pub-id pub-id-type="pmid">27470326</pub-id>
                    <issn>1619-7070</issn>
                </mixed-citation>
            </ref>
            <ref id="b79">
                <label>79. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Berti</surname>
                            <given-names>V</given-names>
                        </name>, 
                        <name>
                            <surname>Mosconi</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Pupi</surname>
                            <given-names>A</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging</article-title>. 
                    <source>PET Clin</source>. 
                    <year>2014</year>
                    <month>Apr</month>;
                    <volume>9</volume>(
                    <issue>2</issue>):
                    <fpage>129</fpage>–
                    <lpage>40</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.cpet.2013.10.006</pub-id>
                    <pub-id pub-id-type="pmid">24772054</pub-id>
                    <issn>1556-8598</issn>
                </mixed-citation>
            </ref>
            <ref id="b80">
                <label>80. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Harper</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Barkhof</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <name>
                            <surname>Scheltens</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Schott</surname>
                            <given-names>JM</given-names>
                        </name>, 
                        <name>
                            <surname>Fox</surname>
                            <given-names>NC</given-names>
                        </name>
                    </person-group>. 
                    <article-title>An algorithmic approach to structural imaging in dementia</article-title>. 
                    <source>J Neurol Neurosurg Psychiatry</source>. 
                    <year>2014</year>
                    <month>Jun</month>;
                    <volume>85</volume>(
                    <issue>6</issue>):
                    <fpage>692</fpage>–
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.1136/jnnp-2013-306285</pub-id>
                    <pub-id pub-id-type="pmid">24133287</pub-id>
                    <issn>0022-3050</issn>
                </mixed-citation>
            </ref>
            <ref id="b81">
                <label>81. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Heiss</surname>
                            <given-names>WD</given-names>
                        </name>, 
                        <name>
                            <surname>Rosenberg</surname>
                            <given-names>GA</given-names>
                        </name>, 
                        <name>
                            <surname>Thiel</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Berlot</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>de Reuck</surname>
                            <given-names>J</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Neuroimaging in vascular cognitive impairment: a state-of-the-art review</article-title>. 
                    <source>BMC Med</source>. 
                    <year>2016</year>
                    <month>Nov</month>;
                    <volume>14</volume>(
                    <issue>1</issue>):
                    <fpage>174</fpage>. 
                    <pub-id pub-id-type="doi">10.1186/s12916-016-0725-0</pub-id>
                    <pub-id pub-id-type="pmid">27806705</pub-id>
                    <issn>1741-7015</issn>
                </mixed-citation>
            </ref>
            <ref id="b82">
                <label>82. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Liu</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Buch</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Chen</surname>
                            <given-names>Y</given-names>
                        </name>, 
                        <name>
                            <surname>Choi</surname>
                            <given-names>HS</given-names>
                        </name>, 
                        <name>
                            <surname>Dai</surname>
                            <given-names>Y</given-names>
                        </name>, 
                        <name>
                            <surname>Habib</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Susceptibility-weighted imaging: current status and future directions</article-title>. 
                    <source>NMR Biomed</source>. 
                    <year>2017</year>
                    <month>Apr</month>;
                    <volume>30</volume>(
                    <issue>4</issue>):
                    <fpage>e3552</fpage>. 
                    <pub-id pub-id-type="doi">10.1002/nbm.3552</pub-id>
                    <pub-id pub-id-type="pmid">27192086</pub-id>
                    <issn>0952-3480</issn>
                </mixed-citation>
            </ref>
            <ref id="b83">
                <label>83. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Schneider</surname>
                            <given-names>SA</given-names>
                        </name>, 
                        <name>
                            <surname>Hardy</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Bhatia</surname>
                            <given-names>KP</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations</article-title>. 
                    <source>Mov Disord</source>. 
                    <year>2012</year>
                    <month>Jan</month>;
                    <volume>27</volume>(
                    <issue>1</issue>):
                    <fpage>42</fpage>–
                    <lpage>53</lpage>. 
                    <pub-id pub-id-type="doi">10.1002/mds.23971</pub-id>
                    <pub-id pub-id-type="pmid">22031173</pub-id>
                    <issn>0885-3185</issn>
                </mixed-citation>
            </ref>
            <ref id="b84">
                <label>84. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Wahlund</surname>
                            <given-names>LO</given-names>
                        </name>, 
                        <name>
                            <surname>Julin</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Johansson</surname>
                            <given-names>SE</given-names>
                        </name>, 
                        <name>
                            <surname>Scheltens</surname>
                            <given-names>P</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study</article-title>. 
                    <source>J Neurol Neurosurg Psychiatry</source>. 
                    <year>2000</year>
                    <month>Nov</month>;
                    <volume>69</volume>(
                    <issue>5</issue>):
                    <fpage>630</fpage>–
                    <lpage>5</lpage>. 
                    <pub-id pub-id-type="doi">10.1136/jnnp.69.5.630</pub-id>
                    <pub-id pub-id-type="pmid">11032615</pub-id>
                    <issn>0022-3050</issn>
                </mixed-citation>
            </ref>
            <ref id="b85">
                <label>85. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Gorno-Tempini</surname>
                            <given-names>ML</given-names>
                        </name>, 
                        <name>
                            <surname>Hillis</surname>
                            <given-names>AE</given-names>
                        </name>, 
                        <name>
                            <surname>Weintraub</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Kertesz</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Mendez</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Cappa</surname>
                            <given-names>SF</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Classification of primary progressive aphasia and its variants</article-title>. 
                    <source>Neurology</source>. 
                    <year>2011</year>
                    <month>Mar</month>;
                    <volume>76</volume>(
                    <issue>11</issue>):
                    <fpage>1006</fpage>–
                    <lpage>14</lpage>. 
                    <pub-id pub-id-type="doi">10.1212/WNL.0b013e31821103e6</pub-id>
                    <pub-id pub-id-type="pmid">21325651</pub-id>
                    <issn>0028-3878</issn>
                </mixed-citation>
            </ref>
            <ref id="b86">
                <label>86. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Massey</surname>
                            <given-names>LA</given-names>
                        </name>, 
                        <name>
                            <surname>Micallef</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Paviour</surname>
                            <given-names>DC</given-names>
                        </name>, 
                        <name>
                            <surname>O’Sullivan</surname>
                            <given-names>SS</given-names>
                        </name>, 
                        <name>
                            <surname>Ling</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Williams</surname>
                            <given-names>DR</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy</article-title>. 
                    <source>Mov Disord</source>. 
                    <year>2012</year>
                    <month>Dec</month>;
                    <volume>27</volume>(
                    <issue>14</issue>):
                    <fpage>1754</fpage>–
                    <lpage>62</lpage>. 
                    <pub-id pub-id-type="doi">10.1002/mds.24968</pub-id>
                    <pub-id pub-id-type="pmid">22488922</pub-id>
                    <issn>0885-3185</issn>
                </mixed-citation>
            </ref>
            <ref id="b87">
                <label>87. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Dukart</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Mueller</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Horstmann</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Barthel</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Möller</surname>
                            <given-names>HE</given-names>
                        </name>, 
                        <name>
                            <surname>Villringer</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Combined Evaluation of FDG-PET and MRI Improves Detection and Differentiation of Dementia</article-title>. 
                    <source>PLoS One</source>. 
                    <year>2011</year>
                    <month>Mar</month>;
                    <volume>6</volume>(
                    <issue>3</issue>):
                    <fpage>e18111</fpage>.
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0018111</pub-id>
                    <pub-id pub-id-type="pmid">21448435</pub-id>
                    <issn>1932-6203</issn>
                </mixed-citation>
            </ref>
            <ref id="b88">
                <label>88. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Fox</surname>
                            <given-names>MD</given-names>
                        </name>, 
                        <name>
                            <surname>Snyder</surname>
                            <given-names>AZ</given-names>
                        </name>, 
                        <name>
                            <surname>Vincent</surname>
                            <given-names>JL</given-names>
                        </name>, 
                        <name>
                            <surname>Corbetta</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Van Essen</surname>
                            <given-names>DC</given-names>
                        </name>, 
                        <name>
                            <surname>Raichle</surname>
                            <given-names>ME</given-names>
                        </name>
                    </person-group>. 
                    <article-title>The human brain is intrinsically organized into dynamic, anticorrelated functional networks</article-title>. 
                    <source>Proc Natl Acad Sci USA</source>. 
                    <year>2005</year>
                    <month>Jul</month>;
                    <volume>102</volume>(
                    <issue>27</issue>):
                    <fpage>9673</fpage>–
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.1073/pnas.0504136102</pub-id>
                    <pub-id pub-id-type="pmid">15976020</pub-id>
                    <issn>0027-8424</issn>
                </mixed-citation>
            </ref>
            <ref id="b89">
                <label>89. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Seeley</surname>
                            <given-names>WW</given-names>
                        </name>, 
                        <name>
                            <surname>Crawford</surname>
                            <given-names>RK</given-names>
                        </name>, 
                        <name>
                            <surname>Zhou</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Miller</surname>
                            <given-names>BL</given-names>
                        </name>, 
                        <name>
                            <surname>Greicius</surname>
                            <given-names>MD</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Neurodegenerative diseases target large-scale human brain networks</article-title>. 
                    <source>Neuron</source>. 
                    <year>2009</year>
                    <month>Apr</month>;
                    <volume>62</volume>(
                    <issue>1</issue>):
                    <fpage>42</fpage>–
                    <lpage>52</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.neuron.2009.03.024</pub-id>
                    <pub-id pub-id-type="pmid">19376066</pub-id>
                    <issn>0896-6273</issn>
                </mixed-citation>
            </ref>
            <ref id="b90">
                <label>90. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Jack</surname>
                            <given-names>CR</given-names>
                            <suffix>Jr</suffix>
                        </name>, 
                        <name>
                            <surname>Bennett</surname>
                            <given-names>DA</given-names>
                        </name>, 
                        <name>
                            <surname>Blennow</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Carrillo</surname>
                            <given-names>MC</given-names>
                        </name>, 
                        <name>
                            <surname>Feldman</surname>
                            <given-names>HH</given-names>
                        </name>, 
                        <name>
                            <surname>Frisoni</surname>
                            <given-names>GB</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers</article-title>. 
                    <source>Neurology</source>. 
                    <year>2016</year>
                    <month>Aug</month>;
                    <volume>87</volume>(
                    <issue>5</issue>):
                    <fpage>539</fpage>–
                    <lpage>47</lpage>. 
                    <pub-id pub-id-type="doi">10.1212/WNL.0000000000002923</pub-id>
                    <pub-id pub-id-type="pmid">27371494</pub-id>
                    <issn>0028-3878</issn>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
</article>
